Key facts: UnitedHealth Group Incorporated Raises 2026 EPS; Q3 Results
UnitedHealth (UNH) reported Q3 2026 adjusted EPS of $4.69, revenue of $112.7B, and raised 2026 adjusted EPS guidance to at least $20.50. Q3 medical care ratio was 88.4%, with YTD buybacks of $5B and dividends of $6.2B. The company aims for 69% of Medicare Advantage members in 4-star plans by 2027 and expects 2026 MA margins near the top of the 2%–4% range. Shares rose in premarket trading.
How this was made
The 30-second read
Why it matters
The guidance lift is a primary market‑moving event for UNH, likely prompting buying interest.
Market read
UNH's guidance raise is a fresh, material development for a mega‑cap health‑care stock, offering a clear trading catalyst.
What to watch
Potential Medicaid drag and regulatory headwinds could temper the upside.
Background
UnitedHealth Group reported Q3 2026 results with revenue slightly down YoY but beating estimates, and announced a significant EPS guidance increase.
Ticker impact
UnitedHealth raised its 2026 adjusted EPS guidance to at least $20.50, the first report of this guidance increase.
upward pressure as investors price in higher future earnings
The EPS guidance lift is a material, fresh disclosure for a large-cap insurer, prompting traders to consider buying on the news.
Market effects
Higher health‑care earnings expectations may lift peers in the insurance and managed‑care space.
U.S. market sentiment could improve, especially in the health‑care sector.
Limited to U.S. equities; no direct global macro impact.
Counterpoint
If cost pressures intensify or policy changes hurt Medicare Advantage margins, the guidance may be overly optimistic.
Key entities
- companyUnitedHealth Group Incorporated
Large U.S. health‑care insurer and the subject of the article.
